Anonymised teardowns of entry decisions that went wrong, and the pattern behind each.
The registration was never in the company's name, and the company only discovered that when it tried to leave.
A price agreed in a small early market travelled, by rule, into every market the company had been saving.
The company optimised for the regulator, then met a second decision maker it had never designed evidence for.
A therapy withdrawn from a market that had done nothing wrong.